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Abstract
Aim Interest in functional bowel disorders (FBDs) and
faecal incontinence (FI) has increased amongst colo-
proctologists. The study aimed to assess the prevalence
of FBDs and FI (including its severity) among Austra-
lian primary healthcare seekers using objective criteria.
Method A cross-sectional survey was conducted in a
primary care setting in Sydney, Australia. A self-adminis-
tered questionnaire was used to collect demographic
information and diagnose FBDs (irritable bowel syn-
drome, constipation, functional bloating and functional
diarrhoea) based on Rome III criteria. The severity of
FI was determined using the Vaizey incontinence score.
Associations with medical/surgical history and health-
care utilization were assessed.
Results Of 596 subjects approached, 396 (66.4%)
agreed to participate. Overall, 33% had FBD and/or
FI. Irritable bowel syndrome was present in 11.1% and
these participants were more likely to report anxiety/
depression (P < 0.01) and to have had a previous colo-
noscopy (P < 0.001) or cholecystectomy (P = 0.02).
Functional constipation was present in 8.1%, and func-
tional bloating and functional diarrhoea were diag-
nosed in 6.1%, and 1.5%, respectively. FI was present
in 12.1% with the majority (52%) reporting moderate/
severe incontinence (Vaizey score > 8). Participants
with FI were more likely to have irritable bowel syn-
drome, urinary incontinence and previous anal surgery
(P < 0.01).
Conclusion FBDs and FI are prevalent conditions
amongst primary healthcare seekers and the needs of
those affected appear to be complex given their coexis-
ting symptoms and conditions. Currently, the majority
do not reach colorectal services, although increased
awareness by primary care providers could lead to suf-
ferers being referred for specialist management.
Keywords Functional bowel disorders, faecal inconti-
nence, pelvic floor disorders, epidemiology, health-ser-
vice provision
What does this paper add to the literature?
This paper is the first to establish the prevalence of
functional bowel disorders and faecal incontinence using
explicit, standardized criteria amongst healthcare seekers
who have the potential to access colorectal services,
rather than in the community. Further, it has identified
important associations of these disorders.
Introduction
Interest in the management of pelvic floor and functional
gastrointestinal disorders (FGIDs) has increased dramati-
cally amongst colorectal surgeons in the last decade,
reflecting the expanding spectrum of non-surgical [1]
and surgical therapeutic options [2,3]. Indeed, the man-
agement of these patients now forms an important part
of the work of the coloproctologist and is no longer con-
fined to a few specialist centres. FGIDs represent various
combinations of chronic or recurrent gastrointestinal
symptoms that are not attributable to gross structural or
biochemical abnormalities [4–6] and thus, in the absence
of objective biomarkers, their diagnosis has relied heavily
on the development of symptom-based criteria. The
most widely accepted are the Rome criteria, which have
provided a structured and comprehensive classification
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system of FGIDs [4,7]. Despite the limitations of a
purely symptom-based taxonomy [8], the Rome criteria
are now published in their third version [9] and are
widely employed to provide consistency in the classifica-
tion of subjects in the research setting. Further, such a
taxonomy is advantageous from a clinical perspective,
since a diagnosis is reached without the need for invasive
investigation [7].
From the perspective of the colorectal surgeon,
FGIDs attributed to dysfunction of the lower gastroin-
testinal tract include the functional bowel disorders
(FBDs) [including irritable bowel syndrome (IBS),
functional constipation, functional bloating and func-
tional diarrhoea] and faecal incontinence (FI). IBS is
characterized by abdominal pain or discomfort associ-
ated with change in bowel frequency and/or consis-
tency [10] and is the most commonly diagnosed
functional disorder [11–13], accounting for up to 36%
of all visits to gastroenterologists [14,15]. Functional
constipation is defined as persistently difficult, infre-
quent or seemingly incomplete defaecation [10], and
was found to affect up to 27% of North Americans in a
recent systematic review [16]. Functional bloating,
defined as a recurrent sensation of abdominal disten-
sion, appears to affect between 16% and 30% of the
population [17], whilst functional diarrhoea, character-
ized by chronic loose/watery stools, had a prevalence of
8.5% in a recent population-based Canadian study [18].
The prevalence of FI, defined as the recurring uncon-
trolled passage of faecal material [19], is more difficult
to measure given the reluctance of sufferers to report
this symptom on account of the associated social
embarrassment and stigma [20], but recent studies sug-
gest that FI may affect up to 17% of the community
[21,22].
These estimates of prevalence suggest that FGIDs
are common with perhaps as many as two-thirds of the
population experiencing at least one functional gastroin-
testinal symptom [5], but previous studies have used
inconsistent criteria for the definition and diagnosis or
have focused on individual bowel disorders in isolation.
Further, all existing studies have been performed in
community-based populations and such measures may
not reflect the prevalence in the health-seeking popula-
tion that can access colorectal services. By contrast,
clinic-based surveys offer unique information about
healthcare seekers [4], potentially assisting with colorec-
tal service planning/provision, but no such studies exist
in the published literature. Therefore, the aim of the
present study was to measure the prevalence of FBDs
and FI (and its severity) among Australians attending
primary healthcare providers using the latest Rome III
criteria and an objective FI scoring system, respectively.
Method
Study population
A cross-sectional survey was conducted amongst indi-
viduals attending four general practices (primary care
providers) in Greater Western Sydney, Australia,
between July 2011 and August 2011. The general prac-
tices were randomly selected from a prospectively main-
tained list of practices actively engaged in medical
education and/or research. All practices were doctor-
owned bulk-billing practices, each with over five general
practitioners. Universal access to primary healthcare is
available in Australia whereby patients receive free or
subsidized treatment (> 85%) by doctors in general
practice [23]. Individuals aged 18 years or older were
invited to participate on a consecutive basis as they
entered into the practice waiting rooms, irrespective of
their reason for attendance. Participants were advised
that the study pertained to their health, but the specific
topic of the study was only revealed if asked by the par-
ticipant. After providing informed consent for study
participation, they each completed a self-administered
questionnaire.
Self-administered questionnaire
The self-administered questionnaire included Rome III
diagnostic criteria for FBDs (IBS, functional constipa-
tion, functional bloating and functional diarrhoea) [10],
as well as details relating to the presence and severity of
symptoms of FI based on the validated modified Cleve-
land Clinic (Vaizey) incontinence scoring system [24].
Specifically, IBS was diagnosed if recurrent abdominal
pain or discomfort was experienced at least 3 days per
month in the last 3 months, with overall symptom
duration for at least 6 months, associated with two or
more of the following: (i) improvement of abdominal
pain with defaecation; (ii) onset of symptoms associated
with a change in frequency of stool; (iii) onset of symp-
toms associated with a change in form or appearance of
stool [10]. Further, based on predominant stool pattern
without the use of anti-diarrhoeals or laxatives, partici-
pants diagnosed with IBS were sub-classified as IBS
with constipation (IBS-C), IBS with diarrhoea (IBS-D),
mixed type IBS (IBS-M) and un-subtyped IBS (IBS-U).
Functional constipation was diagnosed in participants
who did not meet the criteria for IBS but for the last
3 months (with symptom onset at least 6 months previ-
ously) had had two or more of the following: (i) strain-
ing during at least 25% of defaecations; (ii) lumpy or
hard stools in at least 25% of defaecations; (iii) sensation
of incomplete evacuation for at least 25% of defaeca-
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tions; (iv) sensation of anorectal obstruction or block-
age for at least 25% of defaecations; (v) manual
manoeuvres to facilitate at least 25% of defaecations
(e.g. digital evacuation, support of the pelvic floor); or
(vi) fewer than three defaecations per week [10]. Func-
tional bloating was diagnosed when there was a recur-
rent feeling of bloating or visible distension present for
at least 3 days of the month during the last 3 months
with insufficient criteria to reach a diagnosis of IBS
[10], while functional diarrhoea was diagnosed when
there were loose or watery stools without pain occur-
ring in at least 75% of stools during the last 3 months
[10].
Faecal incontinence was defined as leakage of solid
or liquid stool (not flatus) at least once per month.
When this criterion was met, the severity of the inconti-
nence was assessed using the modified Cleveland Clinic
(Vaizey) incontinence score [24]. Participants were
required to report frequency of incontinence to solid
and liquid stools, as well as flatus, as ‘never’, ‘rarely’,
‘sometimes’, ‘weekly’ or ‘daily’. Other items assessed
included (i) alteration in lifestyle, (ii) need to wear a
pad or plug, (iii) need to take constipating medications
and (iv) inability to defer defaecation for at least
15 min. A maximum score of 24 indicated total inconti-
nence, whilst a score of 0 implied perfect continence.
Subsequently, participants with FI were further classified
on the basis of their incontinence score into those with
mild (score 1–8), moderate (score 9–16) or severe
(score 17–24) symptoms. Presence of coexisting urinary
symptoms, particularly urinary incontinence, was also
documented.
The questionnaire also recorded details relating to
(a) participant demographics, including ethnicity, mari-
tal status, employment status, level of education
attained, and smoking and alcohol consumption, and
(b) past history, including (i) previous medical diagno-
ses of IBS, diabetes, mental health issues (self-reported
as anxiety, depression and/or panic attacks), (ii) previ-
ous surgical procedures and (iii) for women, previous
obstetric and/or gynaecological history, including
details of parity, mode of delivery and presence of peri-
neal trauma (e.g. episiotomy, vaginal tear or instrumen-
tal delivery).
Statistical analyses
Survey data were analysed using frequency tabulations
and contingency table analyses. Where appropriate, par-
ticipant characteristics were dichotomized. Association
between various demographic characteristics/past histo-
ries and IBS, constipation and FI were also assessed
and presented as crude odds ratios (OR) with 95%
confidence intervals (95% CI). All analyses were con-
ducted using SAS v9.2 (SAS Institute, Cary, North
Carolina, USA) and P values < 0.05 were considered
statistically significant. This study was approved by the
University of Western Sydney Human Research Ethics
Committee (approval number H9067).
Results
Response rate
Of the 596 individuals approached to complete the sur-
vey, 396 (66.4%) agreed to participate. The reasons for
not doing so included time constraints (42.5%) and lack
of interest (22.5%), with language barriers encountered
in only 5% of participants.
Sample characteristics
Demographic characteristics and pertinent factors in the
medical history are presented in Table 1. The mean age
of the sample was 47  17 years, and 65% were
women. The majority of respondents were Caucasian
(66.3%). Most participants were married (66.3%) and
employed (65.2%) and approximately half (51.9%) had
completed tertiary education (either at university or
vocational trade).
Prevalent medical conditions reported included
depression (14.4%), anxiety (13.3%) and diabetes mell-
itus (11.8%). A significant proportion of participants
had undergone previous abdominal operations and pro-
cedures, including appendicectomy (12.1%) and chole-
cystectomy (5.8%). Only 3.5% of participants reported
having had a previous colonoscopy, while approximately
7% of participants reported previous anal surgery,
the most common being haemorrhoidal surgery. Over
70% of female participants interviewed were parous,
with most reporting previous vaginal delivery and
approximately half experiencing significant perineal
trauma secondary to episiotomy or perineal tear(s) (see
Table 1).
Prevalence of FBD and FI and their associations
The prevalence of FBD and FI are shown in Table 2.
Overall, 33% (95% CI 28–38) of all participants inter-
viewed had either FBD and/or FI. Notably, 11% (95%
CI 8–15) had IBS, 8% (95% CI 6–11) had functional
constipation and 12% (95% CI 9–16) had FI.
Irritable bowel syndrome
Of the sample studied, 44 (11.1%) participants fulfilled
Rome III criteria for IBS, with approximately equal
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proportions of IBS-C (2.8%), IBS-D (3.0%) and IBS-M
(4.5%); only 1.5% of participants were classified as hav-
ing IBS-U (Table 2). Of the participants who met these
diagnostic criteria, 70% (31/44) had never previously
been formally diagnosed with IBS. Conversely, over half
(15/28) of participants who had been given a previous
‘diagnosis’ of IBS failed to satisfy the objective Rome
III criteria.
Irritable bowel syndrome was diagnosed twice as
frequently in Caucasian participants compared with
Table 1 Participant characteristics.
Number
(n = 396) Per cent
Age (years)*






















TAFE/vocational training 62 15.7
High school 178 45.1
Other 12 3.0
Alcohol (standard drinks per day)
0 197 50.1
1 149 37.9
≥ 2 47 12.0
Body mass index*
< 18.5 (underweight) 11 3.1
18.5–25.0 (normal) 130 36.4
25.0–30.0 (overweight) 123 34.5
> 30 (obese) 93 26.1
Smoking status*
Current smoker 36 9.1
Ex smoker 102 25.8
Never smoked 257 65.1
Past history
Diabetes mellitus 46 11.8




Mental health issues 83 21.0
Depression 56 14.4
Anxiety 52 13.3
Previous anal surgery 26 6.7
Fissure 2 0.5
Fistula 6 1.5
Haemorrhoid surgery 17 4.4
Table 1 (Continued).
Number







Constipating medications 35 8.9
Women (n = 258)
Parous 181 70.2
Vaginal delivery 41 22.6
Tear/episiotomy/suction/forceps† 97 53.6
Caesarean section† 43 23.8
Urinary incontinence 95 24.4
*Numbers for these variables do not add to n = 396 because
some participants declined to respond to certain questions.
†Had at least one delivery that was either caesarean section or
tear/episiotomy.
Table 2 Prevalence of functional bowel disorders and faecal
incontinence.
Number Per cent (95% CI)
Irritable bowel syndrome (IBS) 44 11.1 (8.2–14.6)
IBS-C 11 2.8 (1.4–4.9)
IBS-D 12 3.0 (1.6–5.2)
IBS-M 18 4.5 (2.7–7.1)
IBS-U 3 0.8 (0.2–2.2)
Functional constipation 32 8.1 (5.6–11.2)
Functional bloating 24 6.1 (3.9–8.9)
Functional diarrhoea 6 1.5 (0.6–3.3)
Faecal incontinence (FI)
FI (i.e. solid + liquid stool) 48 12.1 (9.1–15.8)
Mild (Vaizey 1–8) 23 47.9
Moderate (Vaizey 9–16) 22 45.8
Severe (Vaizey 17–24) 3 6.3
Solid stool incontinence 19 4.8 (2.9–7.4)
Liquid stool incontinence 29 7.3 (5.0–10.4)
Flatus incontinence only 98 28.6 (23.5–33.2)
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non-Caucasian participants (OR 2.12, 95% CI 0.99–
4.56). There was an increased tendency for IBS to be
diagnosed amongst women, those employed, and those
with tertiary or vocational education (Table 3),
although these associations did not reach statistical sig-
nificance. Participants with ‘self-reported’ symptoms of
mental health issues were over three times more likely
to have IBS (OR 3.42, 95% CI 1.78–6.58). Participants
meeting the Rome III criteria for IBS were over nine
times more likely to have had a previous colonoscopy
(OR 9.32, 95% CI 3.10–28.04) and over three times
more likely to have had a previous cholecystectomy
(OR 3.11, 95% CI 1.16–8.37). There was a tendency
for increased rates of appendicectomy in IBS partici-
pants as well, although this did not reach statistical sig-
nificance (Table 3).
Functional constipation
Rome III criteria for functional constipation were met
in 32 (8.1%) participants (Table 2) of whom only one
reported regular laxative consumption. No significant
associations were identified between constipation and
age, ethnicity or employment status (Table 3).
Increased rates of diabetes, appendicectomy and chole-
cystectomy were also found amongst constipated partic-
ipants, but these did not reach statistical significance.
Functional bloating
Functional bloating was diagnosed in 24 (6.1%) partici-
pants (Table 2). Whilst most cases were diagnosed in
women and those younger than 60 years, associations
with gender and age did not reach statistical significance.
No other demographic associations were observed.
Functional bloating did not appear to influence rates of
colonoscopy, appendicectomy or cholecystectomy.
Functional diarrhoea
Criteria for functional diarrhoea were met in six (1.5%)
participants (Table 2). Whilst significant associations
were identified between functional diarrhoea and age
greater than 60 years (OR 6.37, 95% CI 1.15–35.37),
male gender (OR 9.59, 95% CI 1.11–83.33), alcohol
consumption of two or more standard drinks per day
(OR 7.80, 95% CI 1.53–39.82) and increased body
mass index (P = 0.005), these findings should be inter-
preted with caution given the small number diagnosed.
Faecal incontinence
Overall, 48 (12.1%) participants experienced FI, with
incontinence to solid stool reported by 19 (39.7%) and
to liquid stool (without solid stool incontinence) by the
remaining 29 (60.3%). Of those diagnosed with FI, the
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severe symptoms. Notably, a further 98 participants
(28.6%) who did not fulfil the diagnostic criteria for FI
reported incontinence to flatus alone (Table 2).
A significant proportion of patients experienced
concomitant symptoms of IBS and FI. Specifically,
one-third (n = 13) of patients with IBS had FI; put dif-
ferently, IBS patients were almost four times more likely
to report FI (OR 3.80, 95% CI 1.82–7.93). Previous
anal surgery (for anal fissure, anal fistulae or haemor-
rhoids etc.) increased the risk of FI almost fourfold (OR
3.80, 95% CI 1.55–9.33) (Table 3). Additionally, par-
ticipants with FI were over four times more likely to
have undergone a previous colonoscopy (OR 4.38, 95%
CI 1.40–13.67), over twice as likely to have had a
previous appendicectomy (OR 2.21, 95% CI 1.02–4.80)
and almost three times more likely to have had a previ-
ous cholecystectomy (OR 2.96, 95% CI 1.10–7.99).
However, FI was not significantly associated with age,
gender or ethnicity. Previous obstetric trauma did not
appear to be a significant factor for FI (see Table 3).
Overall, urinary incontinence was reported by one-
quarter of participants, almost all of whom were women
(OR 5.01, 95% CI 2.62–9.59) and Caucasian (OR 1.85,
95% CI 1.10–3.14). Notably, participants who were
incontinent to urine were over three times more likely to
report FI (OR 3.24, 95% CI 1.73–6.08) (see Table 3).
Discussion
This study used explicit and contemporary standardized
criteria and scoring systems to assess the prevalence of
FBDs and FI (and its severity) and confirmed that they
are common, being present in 33% of Australian pri-
mary healthcare seekers. Specifically, the Rome III crite-
ria for IBS were met in 11%, most commonly in
Caucasians, with participants being more likely to report
anxiety and/or depression and have had a previous col-
onoscopy or cholecystectomy. Functional constipation
was present in 8%, with only 3% of patients using laxa-
tive medication. FI was present in 12% of participants
(5% to solid stool and 7% to liquid stool) with the
majority (52%) reporting moderate/severe incontinence.
FI was associated with previous anal and abdominal sur-
gery and concomitant urinary incontinence.
The comparison of prevalence between this and
other published studies is hampered by varying diagnos-
tic criteria and study methodologies employed. For
example, the published prevalence rates of IBS range
from 0.8% to 28% [4]. Only one previous study has
assessed community prevalence of IBS in a Western
population using Rome III criteria, reporting a preva-
lence of 16% [25]. The prevalence of IBS in the present
study (11%) was comparable to that reported in a recent
community-based Australian study, which used Rome II
criteria and diagnosed IBS in 8.9% of subjects [26].
The only previous study focusing on primary healthcare
seekers was conducted over a decade ago and used
Manning criteria and diagnosed IBS in almost one-third
of subjects [27].
The association between IBS and Caucasian ethnicity
demonstrated in the present study has been previously
documented [28], although a reason for this racial pre-
ponderance remains poorly understood. Female gender
and individuals with tertiary education or employment
status have previously been shown to be associated with
IBS [13], although we found no relationship amongst
these factors in the present study. The observed signifi-
cant association between mental health issues (e.g.
depression and anxiety) and IBS has also been well doc-
umented [29], although the issue of cause, effect or
epiphenomenon remains unresolved and cannot be
answered by the present study.
Our study reveals that individuals with IBS were over
nine times more likely to have had a previous colonos-
copy and over three times more likely to have had a
previous cholecystectomy, in keeping with findings from
previous studies [30–32]. The association with colonos-
copy, in pursuit of an organic basis for symptoms, is
perhaps unsurprising. Many investigations are often per-
formed in such subjects with the hope of increasing the
certainty associated with the diagnosis of IBS, but for
the majority of cases these investigations add little to
the overall diagnostic schema [31]. Indeed, the use of
symptom-based taxonomies, such as the Rome III crite-
ria, for population- and clinic-based studies is justified
by the validity and reliability of the objective measures
to diagnose FGIDs based on symptoms alone, without
the need for formal investigations [33].
The prevalence of functional constipation has also
varied significantly in published studies. For example, a
recent systematic review of constipation prevalence in
North America reported rates ranging from 1.9% to
27.2%, although the majority of included studies
reported rates from 12% to 19% [16]. Previous Austra-
lian estimates of the prevalence of constipation have var-
ied from 2.8% [26] to 30.7% [34]. The prevalence of
8% reported in the present study falls within this wide
range from population-based studies although, to the
best of our knowledge, it is the first study to specifically
assess its prevalence among primary healthcare seekers.
The prevalence of FI in the literature ranges from 2%
in the adult population [35] to 15% in more elderly
populations [21,36]. However, rates are much higher in
specific groups, with 50% of nursing home residents
[37] and patients with multiple sclerosis [38] and 20%
of patients with diabetes mellitus [39] reporting FI.
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Accordingly, the prevalence estimates of FI are influ-
enced by the demographics and characteristics of the
population studied. Further, it may be influenced by
variation in the definition used for diagnosis and symp-
tom severity assessment. The prevalence of FI measured
in this study is remarkably similar to that of a previous
Australian population-based community study, which
reported a prevalence of 11.2% [40]. The same study
reported solid and liquid stool incontinence in 2% and
9% of subjects, respectively, compared with rates of 5%
and 7% observed in the present study.
Participants with FI were four times more likely to
have had previous anal surgery. Although the timing of
surgery in relation to the development of symptoms was
not formally explored, anal surgery has been previously
recognized as the most important aetiological factor for
the development of FI in men [41] due to the injurious
effects on anal sphincter function [42]. Interestingly, the
present study did not find an association between obstet-
ric trauma and FI, despite the relationship being previ-
ously documented [20] and presumed secondary to
direct sphincter damage and/or pudendal neuropathy
[43]. Of interest, our findings of a non-association
between obstetric trauma and FI is in agreement with
recent large population-based studies, which instead
identified other factors such as age and diarrhoea to be
much more relevant in predisposing a subject to FI [44].
Additionally, participants with FI were four and three
times more likely to have had a previous colonoscopy
and cholecystectomy, respectively. The association with
colonoscopy may be related to increased rates of lumi-
nal imaging performed in these participants to exclude
an organic basis for FI (e.g. inflammatory bowel disease
or partially obstructing neoplastic lesions). The associa-
tion between FI and previous cholecystectomy has only
been reported in one previous study [44] with no firm
explanation provided. Theoretically, alterations in bile
salt metabolism may alter stool consistency sufficiently
to challenge the sphincter complex and explain the
higher rates of FI in post-cholecystectomy subjects. The
association between FI and previous appendicectomy
demonstrated in the present study has never been previ-
ously documented and remains unexplained. Finally, the
relationship between urinary incontinence and FI is
consistent with previous studies [42,45] and may reflect
pelvic floor dysfunction and/or abnormalities of senso-
rimotor nerve function given that common afferent/
efferent nerves from the sacral spinal cord innervate
these viscera and their sphincters, and may conceivably
be subject to disruption from a common underlying
aetiology [46–48].
Our finding that over one in 10 primary healthcare
seekers report FI is of great clinical relevance to primary
and secondary care providers alike. This is all the more
pertinent given the increasing array of non-surgical and
surgical treatment options currently in the colorectal
surgeon’s armamentarium to manage FI. In recent
years, well-designed and executed randomized, con-
trolled trials [1] have confirmed the clinical effectiveness
of non-surgical interventions, such as optimization of
anti-diarrhoeal agents, physical supports such as anal
plugs, and biofeedback therapy. Surgical interventions
include direct sphincter repair, perianal injection of bi-
omaterials and more complex procedures (reserved for
highly selective cases) such as dynamic graciloplasty and
insertion of an artificial bowel sphincter [49]. Over the
past decade, much interest has surrounded the use of
sacral neuromodulation for the treatment of FI, a pro-
cedure widely accepted to carry minimal morbidity but
with medium-term efficacy rates measured to be as high
as 81% in a recent systematic review [2].
Further to establishing that FBDs and FI are rela-
tively prevalent in the community, our findings high-
light that IBS and constipation remain under-reported
by patients and/or under-diagnosed (and thus probably
under-treated) by medical practitioners. This is demon-
strated by only one-third of participants meeting the
Rome III criteria for IBS having previously been diag-
nosed with the condition, and that only 3% of partici-
pants who met the Rome III criteria for functional
constipation were taking regular laxatives. In addition,
there are continued challenges in relation to the ‘accu-
rate diagnosis’ of FBDs, since over 50% of participants
reporting a previous diagnosis of IBS did not actually
meet the objective Rome III criteria at the time of eval-
uation in this cross-sectional study.
The association with previous abdominal and pelvic
surgery in patients with IBS also warrants discussion.
Previously, it has been reported that excessive medical
treatment, particularly surgery, has been rendered to
sufferers and accounts for the economic burden of IBS
estimated at USD$1.6–10 billion in direct costs and
USD$19.2 billion in indirect costs [14,50]. It is possible
that operative management was (erroneously) performed
in some patients with recurrent abdominal pain in the
belief that there was an organic basis for the development
of recurrent or chronic symptoms (e.g. gallstones or clin-
ical symptoms suggestive of a diagnosis of appendicitis).
Unfortunately, the histopathology of resected specimens
was not readily available for scrutiny to determine
whether organic pathology was identified in these
patients. Conversely, the counter-argument is that such
surgery may promote the genesis of functional disorders
such as IBS [32]. Given the non-experimental cross-sec-
tional design of the study, we cannot definitively estab-
lish the time order of effects and direction of causation.
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The study was limited by the convenience sampling
of medical practices in which these surveys were con-
ducted, as practices were selected primarily from general
practitioners willing to participate in the study rather
than at random. Furthermore, surveys of individuals
attending primary care may be subject to selection bias
as the study population may represent motivated health-
care seekers and/or the ‘worried-well’ in varying pro-
portions which may explain the greater proportion of
women, senior citizens and overseas migrants included
in our sample compared with the New South Wales
adult population [51]. Additionally, for reasons of
patient privacy, the individual reason(s) for seeking pri-
mary care was not ascertained, and it remains unknown
what proportion of participants presented because of
gastrointestinal symptoms. Finally, additional red-flag
symptoms, potentially reflecting underlying organic
pathology, were not sought in the study and thus it is
possible that the symptoms recorded reflected organic
pathology rather than functional disorders in a propor-
tion. However, previous studies have shown that endo-
scopic and radiological investigations identify organic
gastrointestinal lesions in less than 1% of patients who
meet symptom-based criteria for IBS [4,52,53]. Despite
these potential limitations, the universal access of pri-
mary healthcare in Australia, consecutive recruitment of
participants, response rate (66%) and comparability of
our prevalence of FBDs to other community and popu-
lation-based studies increase the generalizability and
robustness of our findings. The use of validated ques-
tions derived from the Rome III criteria for FBDs and
Vaizey incontinence score for FI also allowed objective
assessment of symptoms and meaningful comparisons
with other studies that have used similar criteria.
In conclusion, this study highlights that FBDs and
FI are prevalent in primary healthcare seekers, affecting
up to one-third of patients. Given that the population is
motivated to seek medical attention, it is probable that
sufferers will wish to seek specialist attention should
their symptoms deteriorate with time to become suffi-
ciently severe. Further, it is possible that many more
could be referred for expert multidisciplinary education
and management if primary care providers actively
enquired about symptoms and/or were made aware of
the specialist services provided by colorectal surgeons.
The study has also demonstrated that these disorders
are commonly under-diagnosed or incorrectly diagnosed
and inadequately treated in up to two-thirds of patients.
These findings, and the frequency of complex associa-
tions with other symptoms/conditions, further empha-
size the need for detailed and accurate assessment of
such patients, preferably by expert coloproctologists, to
guide appropriate treatment and identify the small sub-
group that requires surgical intervention.
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